487 related articles for article (PubMed ID: 33280099)
1. FBXO28 causes developmental and epileptic encephalopathy with profound intellectual disability.
Schneider AL; Myers CT; Muir AM; Calvert S; Basinger A; Perry MS; Rodan L; Helbig KL; Chambers C; Gorman KM; King MD; Donkervoort S; Soldatos A; Bönnemann CG; Spataro N; Gabau E; Arellano M; Cappuccio G; Brunetti-Pierri N; Rossignol E; Hamdan FF; Michaud JL; Balak C; Mefford HC; Scheffer IE
Epilepsia; 2021 Jan; 62(1):e13-e21. PubMed ID: 33280099
[TBL] [Abstract][Full Text] [Related]
2. A novel FBXO28 frameshift mutation in a child with developmental delay, dysmorphic features, and intractable epilepsy: A second gene that may contribute to the 1q41-q42 deletion phenotype.
Balak C; Belnap N; Ramsey K; Joss S; Devriendt K; Naymik M; Jepsen W; Siniard AL; Szelinger S; Parker ME; Richholt R; Izatt T; LaFleur M; Terraf P; Llaci L; De Both M; Piras IS; Rangasamy S; Schrauwen I; Craig DW; Huentelman M; Narayanan V
Am J Med Genet A; 2018 Jul; 176(7):1549-1558. PubMed ID: 30160831
[TBL] [Abstract][Full Text] [Related]
3. The phenotypic spectrum of X-linked, infantile onset ALG13-related developmental and epileptic encephalopathy.
Datta AN; Bahi-Buisson N; Bienvenu T; Buerki SE; Gardiner F; Cross JH; Heron B; Kaminska A; Korff CM; Lepine A; Lesca G; McTague A; Mefford HC; Mignot C; Milh M; Piton A; Pressler RM; Ruf S; Sadleir LG; de Saint Martin A; Van Gassen K; Verbeek NE; Ville D; Villeneuve N; Zacher P; Scheffer IE; Lemke JR
Epilepsia; 2021 Feb; 62(2):325-334. PubMed ID: 33410528
[TBL] [Abstract][Full Text] [Related]
4. First report of Tunisian patients with CDKL5-related encephalopathy.
Charfi Triki C; Zouari Mallouli S; Ben Jdila M; Ben Said M; Kamoun Feki F; Weckhuysen S; Masmoudi S; Fakhfakh F
Epilepsia Open; 2024 Jun; 9(3):906-917. PubMed ID: 37701975
[TBL] [Abstract][Full Text] [Related]
5. MED13 mutation: A novel cause of developmental and epileptic encephalopathy with infantile spasms.
Trivisano M; De Dominicis A; Micalizzi A; Ferretti A; Dentici ML; Terracciano A; Calabrese C; Vigevano F; Novelli G; Novelli A; Specchio N
Seizure; 2022 Oct; 101():211-217. PubMed ID: 36087421
[TBL] [Abstract][Full Text] [Related]
6.
Vlaskamp DRM; Shaw BJ; Burgess R; Mei D; Montomoli M; Xie H; Myers CT; Bennett MF; XiangWei W; Williams D; Maas SM; Brooks AS; Mancini GMS; van de Laar IMBH; van Hagen JM; Ware TL; Webster RI; Malone S; Berkovic SF; Kalnins RM; Sicca F; Korenke GC; van Ravenswaaij-Arts CMA; Hildebrand MS; Mefford HC; Jiang Y; Guerrini R; Scheffer IE
Neurology; 2019 Jan; 92(2):e96-e107. PubMed ID: 30541864
[TBL] [Abstract][Full Text] [Related]
7. Neurochemistry evaluated by magnetic resonance spectroscopy in a patient with FBXO28-related developmental and epileptic encephalopathy.
Sano K; Miya F; Kato M; Omata T; Takanashi JI
Brain Dev; 2023 Nov; 45(10):583-587. PubMed ID: 37543484
[TBL] [Abstract][Full Text] [Related]
8. Refinement of the critical region of 1q41q42 microdeletion syndrome identifies FBXO28 as a candidate causative gene for intellectual disability and seizures.
Au PY; Argiropoulos B; Parboosingh JS; Micheil Innes A
Am J Med Genet A; 2014 Feb; 164A(2):441-8. PubMed ID: 24357076
[TBL] [Abstract][Full Text] [Related]
9. WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk.
Oliver KL; Trivisano M; Mandelstam SA; De Dominicis A; Francis DI; Green TE; Muir AM; Chowdhary A; Hertzberg C; Goldhahn K; Metreau J; Prager C; Pinner J; Cardamone M; Myers KA; Leventer RJ; Lesca G; Bahlo M; Hildebrand MS; Mefford HC; Kaindl AM; Specchio N; Scheffer IE
Epilepsia; 2023 May; 64(5):1351-1367. PubMed ID: 36779245
[TBL] [Abstract][Full Text] [Related]
10. The molecular and phenotypic spectrum of IQSEC2-related epilepsy.
Zerem A; Haginoya K; Lev D; Blumkin L; Kivity S; Linder I; Shoubridge C; Palmer EE; Field M; Boyle J; Chitayat D; Gaillard WD; Kossoff EH; Willems M; Geneviève D; Tran-Mau-Them F; Epstein O; Heyman E; Dugan S; Masurel-Paulet A; Piton A; Kleefstra T; Pfundt R; Sato R; Tzschach A; Matsumoto N; Saitsu H; Leshinsky-Silver E; Lerman-Sagie T
Epilepsia; 2016 Nov; 57(11):1858-1869. PubMed ID: 27665735
[TBL] [Abstract][Full Text] [Related]
11. The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy.
Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
Epileptic Disord; 2020 Oct; 22(5):563-570. PubMed ID: 33000761
[TBL] [Abstract][Full Text] [Related]
12. Three novel patients with epileptic encephalopathy due to biallelic mutations in the PLCB1 gene.
Desprairies C; Valence S; Maurey H; Helal SI; Weckhuysen S; Soliman H; Mefford HC; Spentchian M; Héron D; Leguern E; Nava C; Bouilleret V; Moretti R; Mignot C
Clin Genet; 2020 Mar; 97(3):477-482. PubMed ID: 31883110
[TBL] [Abstract][Full Text] [Related]
13. ATP1A2-related epileptic encephalopathy and movement disorder: Clinical features of three novel patients.
Córdoba NM; Lince-Rivera I; Gómez JLR; Rubboli G; De la Rosa SO
Epileptic Disord; 2024 Jun; 26(3):332-340. PubMed ID: 38512072
[TBL] [Abstract][Full Text] [Related]
14. Chromosome 9q33q34 microdeletion with early infantile epileptic encephalopathy, severe dystonia, abnormal eye movements, and nephroureteral malformations.
Matsumoto H; Zaha K; Nakamura Y; Hayashi S; Inazawa J; Nonoyama S
Pediatr Neurol; 2014 Jul; 51(1):170-5. PubMed ID: 24938147
[TBL] [Abstract][Full Text] [Related]
15. Developmental and epilepsy spectrum of KCNB1 encephalopathy with long-term outcome.
Bar C; Kuchenbuch M; Barcia G; Schneider A; Jennesson M; Le Guyader G; Lesca G; Mignot C; Montomoli M; Parrini E; Isnard H; Rolland A; Keren B; Afenjar A; Dorison N; Sadleir LG; Breuillard D; Levy R; Rio M; Dupont S; Negrin S; Danieli A; Scalais E; De Saint Martin A; El Chehadeh S; Chelly J; Poisson A; Lebre AS; Nica A; Odent S; Sekhara T; Brankovic V; Goldenberg A; Vrielynck P; Lederer D; Maurey H; Terrone G; Besmond C; Hubert L; Berquin P; Billette de Villemeur T; Isidor B; Freeman JL; Mefford HC; Myers CT; Howell KB; Rodríguez-Sacristán Cascajo A; Meyer P; Genevieve D; Guët A; Doummar D; Durigneux J; van Dooren MF; de Wit MCY; Gerard M; Marey I; Munnich A; Guerrini R; Scheffer IE; Kabashi E; Nabbout R
Epilepsia; 2020 Nov; 61(11):2461-2473. PubMed ID: 32954514
[TBL] [Abstract][Full Text] [Related]
16. PIGN encephalopathy: Characterizing the epileptology.
Bayat A; de Valles-Ibáñez G; Pendziwiat M; Knaus A; Alt K; Biamino E; Bley A; Calvert S; Carney P; Caro-Llopis A; Ceulemans B; Cousin J; Davis S; des Portes V; Edery P; England E; Ferreira C; Freeman J; Gener B; Gorce M; Heron D; Hildebrand MS; Jezela-Stanek A; Jouk PS; Keren B; Kloth K; Kluger G; Kuhn M; Lemke JR; Li H; Martinez F; Maxton C; Mefford HC; Merla G; Mierzewska H; Muir A; Monfort S; Nicolai J; Norman J; O'Grady G; Oleksy B; Orellana C; Orec LE; Peinhardt C; Pronicka E; Rosello M; Santos-Simarro F; Schwaibold EMC; Stegmann APA; Stumpel CT; Szczepanik E; Terczyńska I; Thevenon J; Tzschach A; Van Bogaert P; Vittorini R; Walsh S; Weckhuysen S; Weissman B; Wolfe L; Reymond A; De Nittis P; Poduri A; Olson H; Striano P; Lesca G; Scheffer IE; Møller RS; Sadleir LG
Epilepsia; 2022 Apr; 63(4):974-991. PubMed ID: 35179230
[TBL] [Abstract][Full Text] [Related]
17. Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.
Kim HG; Rosenfeld JA; Scott DA; Bénédicte G; Labonne JD; Brown J; McGuire M; Mahida S; Naidu S; Gutierrez J; Lesca G; des Portes V; Bruel AL; Sorlin A; Xia F; Capri Y; Muller E; McKnight D; Torti E; Rüschendorf F; Hummel O; Islam Z; Kolatkar PR; Layman LC; Ryu D; Kong IK; Madan-Khetarpal S; Kim CH
Mol Autism; 2019; 10():35. PubMed ID: 31649809
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel BCL11A variants in patients with epileptic encephalopathy: Expanding the phenotypic spectrum.
Yoshida M; Nakashima M; Okanishi T; Kanai S; Fujimoto A; Itomi K; Morimoto M; Saitsu H; Kato M; Matsumoto N; Chiyonobu T
Clin Genet; 2018 Feb; 93(2):368-373. PubMed ID: 28589569
[TBL] [Abstract][Full Text] [Related]
19. Dystonia as a prominent presenting feature in developmental and epileptic encephalopathies: A case series.
Dzinovic I; Škorvánek M; Necpál J; Boesch S; Švantnerová J; Wagner M; Havránková P; Pavelekova P; Haň V; Janzarik WG; Berweck S; Diebold I; Kuster A; Jech R; Winkelmann J; Zech M
Parkinsonism Relat Disord; 2021 Sep; 90():73-78. PubMed ID: 34399161
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic features of 1q41q42 microdeletion including WDR26 and FBXO28 are clinically recognizable: The first case from Japan.
Yanagishita T; Yamamoto-Shimojima K; Nakano S; Sasaki T; Shigematsu H; Imai K; Yamamoto T
Brain Dev; 2019 May; 41(5):452-455. PubMed ID: 30635136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
